DNA COMPOSITIONS AND RELATED METHODS

Modulation of Apolipoprotein C-III (ApoCIII) Expression in Lipoprotein Lipase Deficient (LPLD) Populations

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

TREATING AND PREVENTING MICROBIAL INFECTIONS

TREATING AND PREVENTING MICROBIAL INFECTIONS

RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE

CONSTRUCT COMPRISING UTR SEQUENCE THAT IMPROVES INTRACELLULAR STABILITY AND BIOSYNTHESIS OF MRNA AND USE THEREOF

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

METHOD FOR REDUCING THE RISK OF A CARDIOVASCULAR EVENT WITH CONJUGATED ANTISENSE COMPOUNDS TARGETING APO(A)

TREATING AND PREVENTING MICROBIAL INFECTIONS

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

METHODS AND COMPOSITIONS FOR SELECTIVELY ELIMINATING CELLS OF INTEREST

ANTIBODY-DRUG CONJUGATE WITH IMPROVED THERAPEUTIC WINDOW

NUCLEIC ACID COMPOUNDS

DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS

SMALL INTERFERING RNA TARGETING CFB AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN

MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION

Compositions and Methods for Treating Cancer

DUAL-ACTING siRNA BASED MODULATION OF C9orf72

CALCIUM SALTED SPHERICAL NUCLEIC ACIDS

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

COMPOSITIONS AND METHODS FOR TREATMENT OF MICROSATELLITE DNA EXPANSION DISORDERS

COMPOSITIONS AND THERAPEUTIC METHODS OF MICRORNA GENE DELIVERY

DNA APTAMERS AS UNIVERSAL INHIBITORS OF SPIKE PROTEIN/HACE2 INTERACTIONS

TREATMENT OF SOS2 RELATED DISEASES AND DISORDERS

SIRNA FOR INHIBITING ANGPTL3 GENE EXPRESSION AND USE THEREOF

TREATING CANCER WITH CAS ENDONUCLEASE COMPLEXES

NOVEL RNA CONSTRUCT AND METHODS OF USE THEREOF FOR ENHANCING THE THERAPEUTIC EFFECTS OF CYTOTOXIC CELLS AND STEM CELLS

COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS

METHODS FOR TREATING HYPERCHOLESTEROLEMIA

CHIRAL DESIGN

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

Saponin Conjugates

SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOSTIMULATORY AGENTS FOR PROPHYLACTIC AND THERAPEUTIC USE

GPC3 APTAMERS AND VARIANTS AND USE THEREOF

OLIGONUCLEOTIDES FOR PRNP MODULATION

SELECTIVELY ALTERING MICROBIOTA FOR IMMUNE MODULATION

SYNAPTOSOMAL MICRO RNAS AND SYNAPSE FUNCTIONS IN ALZHEIMER'S DISEASE

DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS

TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING

Methods Of Treating Decreased Bone Mineral Density With Cluster Of Differentiation 109 (CD109) Inhibitors

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms

METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY

Methods Of Treating Liver Diseases With Phosphodiesterase 3B (PDE3B) Inhibitors

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES

Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD

TREATMENT FOR NUCLEOTIDE REPEAT EXPANSION DISEASE

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

T CELLS WITH IMPROVED FUNCTIONALITY

MODULATION OF MICRORNA-335-5P FOR THE TREATMENT OF SODIUM CHANNELOPATHIES

METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS

Interferon Production Using Short RNA Duplexes

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION

COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION

ANGELMAN SYNDROME ANTISENSE TREATMENT

METHODS AND COMPOSITIONS FOR INHIBITING DETOXIFICATION RESPONSE

OLIGONUCLEOTIDES FOR SNCA MODULATION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS

Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides

RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

METHODS TO IDENTIFY AND TREAT SUBJECTS HAVING CORTICOSTEROID-RESISTANT INFLAMMATORY DISEASES

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES

SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

BIOACTIVE RENAL CELLS

TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Aptamer for DKK1 and Use Thereof

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

MLK-Regulated microRNAs in Angiogenesis and Tumor Development

Antisense Oligonucleotide (ASO) Gene Inhibition and Treatment

GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS

COMPOUNDS TARGETING PMP22 FOR THE TREATMENT OF CHARCOT-MARIE-TOOTH DISEASE

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

RNA EDITING

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF DUX4

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE

CTLA-4 APTAMER CONJUGATES

ASSESSING RISK FOR COLORECTAL ADENOMA RECURRENCE BY NONINVASIVE MEANS

MANIPULATED IMMUNOREGULATORY ELEMENT AND IMMUNITY ALTERED THEREBY

COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION

SMALL INTERFERING RNA TARGETING CFB AND USES THEREOF

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

RNAi AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

COMPOSITIONS AND THERAPEUTIC METHODS OF MICRORNA GENE DELIVERY

MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION

Heteronucleic acid containing scpBNA or AmNA

Aptamer for specifically recognizing soluble ST2 protein and application of the same

METHODS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES OR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF

Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

TREATMENT OF TUMORS WITH MIRNA TARGETING CDK4/CDK6

SPINAL MUSCULAR ATROPHY (SMA) TREATMENT VIA TARGETING OF SMN2 SPLICE SITE INHIBITORY SEQUENCES

TMEM173 saRNA Compositions and Methods of Use

MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY

BIALLELIC KNOCKOUT OF TRAC

MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF

OLIGONUCLEIC ACID VARIANT LIBRARIES AND SYNTHESIS THEREOF

Lipid formulations for delivery of therapeutic agents

MODULATORS AND MODULATION OF THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS RNA

MODULATION OF GYS1 EXPRESSION

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

METHODS AND COMPOSITIONS FOR CONTROL OF ARTHROPOD PESTS

OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72

MODULATION OF TRANSTHYRETIN EXPRESSION

INHIBITION OF EXPANSION AND FUNCTION OF PATHOGENIC AGE-ASSOCIATED B CELLS AND USE FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASE

PRION PROTEIN (PRNP) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND KITS FOR DETECTING A RISK FOR DEVELOPING NEUROLOGICAL OR NEUROPHYSIOLOGICAL DISORDERS

METHODS AND COMPOSITIONS RELATED TO T-CELL ACTIVITY

Novel Structurally Designed shRNAs

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS

MIR-7-5P MIMIC FOR INHIBITING MIGRATION AND INVASION OF BREAST CANCER, SCREENING METHOD AND APPLICATION THEREOF

LOCALIZED THERAPY OF LOWER AIRWAYS INFLAMMATORY DISORDERS WITH PROINFLAMMATORY CYTOKINE INHIBITORS

COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS

Oligomers and oligomer conjugates

COMPOSITIONS FOR AND METHODS OF ENHANCING TISSUE REGENERATION

MODULATING HEMATAOPOIESIS AND MYLEOID CELL PRODUCTION

RNA PREPARATIONS COMPRISING PURIFIED MODIFIED RNA FOR REPROGRAMMING CELLS

Albumin Production and Cell Proliferation

NUCLEIC ACID MOLECULES WITH INCREASED GENE SILENCING ACTIVITY AND USES THEREOF

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Methods for treating or preventing ophthalmological conditions

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

Morpholinos with Increased Delivery Efficiency

IN UTERO AND POSTNATAL GENE EDITING AND THERAPY FOR TREATMENT OF MONOGENIC DISEASES, INCLUDING MUCOPOLYSACCHARIDOSIS TYPE 1H AND OTHER DISORDERS

DOUBLE-STRANDED RNA THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND PHARMACEUTICAL COMPOSITION

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

NOVEL USE OF HIC-5 INHIBITOR

Angelman syndrome antisense treatment

Treatment of amyotrophic lateral sclerosis (ALS)

METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS

Genetic Construct

FLUOROARABINO NUCLEIC ACID (FANA) APTAMERS THAT BIND SARS-2 RECEPTOR BINDING DOMAIN AND BLOCK BINDING TO THE ACE2 CELLULAR RECEPTOR

CORNEAL ENDOTHELIUM ECM THERAPEUTIC MEDICAMENTS

EXPRESSION CONTROL USING A REGULATABLE INTRON

METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES

EFFICACIOUS MRNA VACCINES

Treatment of Airway Conditions by Modulation of MiR200 Family MicroRNAs

Single-stranded RNA-editing oligonucleotides

MIR-96-5P INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Lipidoids for Nucleic Acid Transfection and Use Thereof

Compositions and methods for inhibiting expression of transthyretin

DNA compositions and related methods

RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE

NUTRITIONAL COMPOSITION COMPRISING MIR-3126

NOVEL HYALURONIDASE VARIANTS WITH IMPROVED STABILITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

PROCESS FOR PRODUCING LIVER CELLS

Lipid formulations for delivery of therapeutic agents

Selectively altering microbiota for immune modulation

ENGINEERED IMMUNE CELL FOR ALLOTRANSPLANTATION

STING-DEPENDENT ACTIVATORS FOR TREATMENT OF DISEASE

COMPOUNDS AND METHODS FOR REDUCING MSH3 EXPRESSION

Compounds and Methods for Reducing ATXN3 Expression

SPECIFIC DECOLONIZATION OF ANTIBIOTIC RESISTANT BACTERIA FOR PROPHYLACTIC PURPOSES

MICRORNA AS A THERAPEUTIC AGENT

Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereof

MONOCYTE PURIFICATION METHOD IN PERIPHERAL BLOOD RAW MATERIAL COLLECTION/ FREEZING-THAWING STEP

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES

FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE SKIN GRAFT HEALING

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING

METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE SYNDROME

Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

TREATMENT OF VIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME

COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA

ENGINEERED NUCLEIC ACIDS AND USES THEREOF

METHOD OF STIMULATING PROLIFERATION OF A CELL

ANTISENSE OLIGONUCLEOTIDE OF CALM2

COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION MOTIF

RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE

MODIFIED SHORT-INTERFERING RNA COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER

ALPHA-2A ADRENERGIC RECEPTOR (ADRA2A) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

MANNAN BINDING LECTIN SERINE PEPTIDASE 2 (MASP2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

ONCOLYTIC VIRAL VECTORS AND USES THEREOF

Angleman syndrome antisense treatment

Transthyretin (TTR) iRNA compositions and methods of use thereof

COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-1 ANTITRYPSIN EXPRESSION

COMPOSITIONS AND METHODS TO TREAT NEUROLOGICAL DISEASES

RNAS FOR COMPLEMENT INHIBITION

Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2)-Mediated Immune Response

INHIBITION OF TAP63 REGULATED ONCOGENIC LONG NON-CODING RNAS (TROLLS) IN THE TREATMENT OF CANCER

Thrombin Binding Circular Aptamer and Use Thereof

Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS

Compositions and methods for treating cancer

Nucleic acids for inhibiting expression of C3 in a cell

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

Nucleic acids for inhibiting expression of PROS1 in a cell

Modulators and modulation of the receptor for advanced glycation end-products RNA

RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES

CHEMICALLY MODIFIED OLIGONUCLEOTIDES TARGETING BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) FOR IMMUNOTHERAPY

Hippo and dystrophin complex signaling in cardiomyocyte renewal

COMPOSITIONS AND METHODS FOR DECREASING TAU EXPRESSION

METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)

Modulation of Angiopoietin-Like 3 Expression

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF

RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Inhibitors Of RNA Editing And Uses Thereof

Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128

METHOD OF STIMULATING PROLIFERATION OF A CELL

ANTISENSE OLIGONUCLEOTIDES (ASOs) DESIGNED TO INHIBIT IMMUNE CHECKPOINT PROTEINS

COMPOSITION FOR DIAGNOSIS OR TREATMENT OF A CONDITION ASSOCIATED WITH INCREASED ACTIVITY OF EIF4E COMPRISING AN EIF4E INHIBITOR

Oligonucleotide-ligand conjugates and process for their preparation

Methods for treating SARS-CoV-2 infection

Nucleic Acid Compounds that Bind to Retinoic Acid-Inducible Gene I Protein

NUCLEIC ACID THAT INHIBITS EXPRESSION OF MEX3B GENE, MEX3B GENE EXPRESSION INHIBITING AGENT, METHOD FOR INHIBITING MEX3B GENE EXPRESSION, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASE CAUSED BY MEX3B GENE EXPRESSION

VASCULOGENIC FIBROBLASTS

SMALL INTERFERING RNA (siRNA) FOR INHIBITING THE EXPRESSION OF MINI-CHROMOSOME MAINTENANCE 7 (MCM7) GENE, AND COMPOSITION AND USE THEREOF

COMPOSITIONS, SYSTEMS AND METHODS FOR CELL THERAPY

IMPROVED ANTIBODY-OLIGONUCLEOTIDE CONJUGATE

SEQUENCE-SPECIFIC IN VIVO CELL TARGETING

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

RNA-Editing Enzyme-Recruiting Oligonucleotides and Uses Thereof

PROCESS OF DELIVERING SMALL RNAS TO SPERM

Strategy to increase anti-viral, anti-microbial, and anti-fungal defense

HUMAN HEAD AND NECK CANCER TREATMENT

miRNAS FOR REDUCING VENTRICLE ENLARGEMENT

A Method Of Promoting Survival And/Or Function Of A Motor Neuron And Related Agents, Uses And Methods

COMPOSITIONS AND METHODS FOR MODULATING SPLICING AND PROTEIN EXPRESSION

Methods to detect motor neuron disease comprising micro-RNAs

Treating and preventing microbial infections

CONJUGATES AND METHODS FOR TREATING ACROMEGALY

METHOD OF MODULATING ADIPOSITY

TREATING AND PREVENTING MICROBIAL INFECTIONS

COMPOSITIONS AND METHODS FOR MATURING STEM CELL-DERIVED BETA CELLS

RNA INTERFERENCE-INDUCING NUCLEIC ACID INHIBITING NONCANONICAL TARGETS OF MICRO RNA, AND USE FOR SAME

HSD17B13 variants and uses thereof

Treating and preventing microbial infections

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE

OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA

Compositions and Methods for Monitoring, Diagnosis, Detection and Treatment of Cancer

APTAMERS AGAINST GLIOBLASTOMA

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer

MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION

CORRECTION OF THE TWO MOST PREVALENT USH2A MUTATIONS BY GENOME EDITING

MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS

Treatment of amyotrophic lateral sclerosis (ALS)

SIRT1-SARNA COMPOSITIONS AND METHODS OF USE

Nanoparticle to target cancer

RNAi agents for inhibiting expression of HIF-2 alpha (), compositions thereof, and methods of use

MOLECULAR MARKER DETECTION AND REGULATING METHODS IN DE-SERVITIZATION STATE OF CELLS

OLIGOMERS

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF C3 IN A CELL

Novel Process for Preparing Rhenium Chelated MAG3 Oligonucleotides

VIRAL VECTORS FOR THE TREATMENT OF DIABETES

CD40 Specific DNA Aptamers as Vaccine Adjuvants

T-lymphocyte binding aptamers

MicroRNA-198 as a tumor suppressor in ovarian cancer

Methods for treating or preventing ophthalmological conditions

Nucleic acids for inhibiting expression of LPA in a cell

NOVEL METHOD FOR MONITORING ENDOMETRIOSIS AND ASSOCIATED DISORDERS

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION

Mammalian somatic cell with modified RNA encoding reprogramming factors

Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases

COMPOSITIONS AND METHODS FOR IN VIVO EXCISION OF HIV-1 PROVIRAL DNA

NOVEL NUCLEIC ACID MOLECULES AND THEIR USE IN THERAPY

CHMP2A as a Regulator of Natural Killer Cell-Mediated Activity

CAS9 VARIANTS WITH ENHANCED SPECIFICITY

CTLA-4 aptamer conjugates

NEW BIOMARKERS AND BIOTARGETS IN RENAL CELL CARCINOMA

COMPOSITIONS FOR SUPPRESSING TRIM28 AND USES THEREOF

TARGETING SENESCENT CELLS

DIAGNOSIS AND TREATMENT OF MEDULLOBLASTOMA

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

COMPOSITIONS AND METHODS FOR ALLEVIATING PAIN

COMPOSITION COMPRISING A MIXTURE OF DNA MOLECULES, USES THEREOF AS BIOLOGICAL INHIBITOR AND METHOD FOR PRODUCTION

Polycomb-associated Non-Coding RNAs

Therapeutic alteration of transplantable tissues through or exposure to RNA interference molecules

EXOSOMES AND MICRO-RIBONUCLEIC ACIDS FOR TISSUE REGENERATION

ADVANCED CHIMERIC ANTIGEN RECEPTOR VECTORS FOR TARGETING SOLID TUMORS